Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin Followed by Voriconazole for Candidemia and Invasive Candidiasis
NCT00548262Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 5
01
Overview
A Phase 4 trial of anidulafungin in candidemia, invasive candidiasis, sponsored by Pfizer. Started Feb 2008; status: completed.
02
Drugs
anidulafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT00548262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548262.